Two new mutations identified as possible causes of rare blood disorder

Researchers have uncovered two novel gene mutations that may be responsible for a rare blood disorder. The mutations are found on the GNE gene and impact an enzyme, also called GNE, that is involved in the synthesis of sialic acid and a process called sialylation, which is critical for brain development. The mutations were first identified in a pediatric patient with macrothrombocytopenia, also called a giant platelet disorder, because of the enlarged size of blood platelets.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup